neuraxpharm Arzneimittel GmbH secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Clonazepam, ATC N03AE01 (OBG) for the period 01082024 - 31072026

Germany, Sept. 2 -- Germany based neuraxpharm Arzneimittel GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Clonazepam, ATC N03AE01 (OBG) for the period 01082024 - 31072026. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....